Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Clinical trial NCT01468350 · COMPLETED
Trial details
- NCT number
- NCT01468350
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.